ID: ALA5266151

Max Phase: Preclinical

Molecular Formula: C12H17NO4

Molecular Weight: 239.27

Associated Items:

Representations

Canonical SMILES:  Cc1cc(=O)c(O)c(CN2CCC(O)CC2)o1

Standard InChI:  InChI=1S/C12H17NO4/c1-8-6-10(15)12(16)11(17-8)7-13-4-2-9(14)3-5-13/h6,9,14,16H,2-5,7H2,1H3

Standard InChI Key:  DMIJPLCBZSEDRJ-UHFFFAOYSA-N

Associated Targets(non-human)

Mycolicibacterium smegmatis 8003 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 239.27Molecular Weight (Monoisotopic): 239.1158AlogP: 0.61#Rotatable Bonds: 2
Polar Surface Area: 73.91Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.38CX Basic pKa: 6.62CX LogP: -0.27CX LogD: -0.35
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.79Np Likeness Score: 0.16

References

1. He M, Fan M, Peng Z, Wang G..  (2021)  An overview of hydroxypyranone and hydroxypyridinone as privileged scaffolds for novel drug discovery.,  221  [PMID:34023737] [10.1016/j.ejmech.2021.113546]

Source